Direkt zum Inhalt
Merck

Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents.

European journal of pharmacology (2003-04-23)
Atticus H Hainsworth, Nicolle C L McNaughton, Alexey Pereverzev, Toni Schneider, Andrew D Randall
ZUSAMMENFASSUNG

Relatively little has been published on the pharmacology of R-type and T-type Ca(2+) channels. Here, whole-cell Ca(2+) channel currents were recorded from human embryonic kidney 293 cell-lines transfected with either alpha1E subunits (R-type currents) or alpha1G or alpha1I subunits (T-type currents). R-type currents were inhibited by sipatrigine and the related compound 202W92 (R-(-)-2,4-diamino-6-(fluromethyl)-5-(2,3,5-trichlorophenyl)pyrimidine) with IC(50) 10 and 56 microM, respectively. A therapeutic concentration of lamotrigine (10 microM) inhibited R-type currents (30%) but was without effect on alpha1I-mediated T-type currents. Lamotrigine was also a weak inhibitor of T-type currents mediated by alpha1G subunits (<10% inhibition by 100 microM).